Quantcast

Latest Income Stories

2014-10-30 08:39:11

GREENVILLE, S.C., Oct. 30, 2014 /PRNewswire/ -- KEMET Corporation (the "Company") (NYSE: KEM), a leading global supplier of electronic components, today reported preliminary results for our second quarter ended September 30, 2014. Net sales of $215.3 million for the quarter ended September 30, 2014 increased 3.3% compared to net sales of $208.4 million for the quarter ended September 30, 2013. The U.S. GAAP net income from continuing operations was $7.7 million, or $0.15 per diluted share...

2014-10-30 08:39:00

US $ -- Q3 adjusted EBITDA of $112 million / net income of $0.18 per share, excluding special items -- Strong performances once again for wood products and pulp -- Thunder Bay pellet plant ramping up; Ignace sawmill about to start -- Closure costs and impairment contribute to GAAP net loss of $116 million / $1.23 per share MONTREAL, Oct. 30, 2014 /PRNewswire/ - Resolute Forest Products Inc. (NYSE: RFP)...

2014-10-30 08:38:44

WHITE PLAINS, N.Y., Oct. 30, 2014 /PRNewswire/ -- Bunge Limited (NYSE:BG) -- Total adjusted segment EBIT of $316 million, down $72 million vs. last year -- Full-year outlook remains positive; anticipate meeting or exceeding targeted combined Agribusiness-Foods ROIC of 1.5 points over WACC -- Agribusiness negatively affected by slow farmer selling and ~$80 million mark-to-market hedging impact, which is largely expected to reverse upon...

2014-10-30 08:35:27

Company Records $3.7 million in Operating income on $33.5 million in revenue MARIETTA, Ga., Oct. 30, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its results for the third quarter ended September 30,...

2014-10-30 08:35:03

Company Raises Full-Year Revenue Guidance to $85.0 to $86.5 Million FT. MYERS, Fla., Oct. 30, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2014. Third Quarter 2014 Highlights: -- 38% increase in consolidated revenue -- 23% growth in base NeoGenomics revenue -- 33% growth in base NeoGenomics test volume -- Consolidated Adjusted EBITDA increase of...

2014-10-30 08:34:56

- Solid third quarter results reported and strong fourth quarter expected - EAST RUTHERFORD, N.J., Oct. 30, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) reports results for the third quarter ended September 30, 2014. Highlights -- Third quarter sales increased 4.0% to $81.1 million from $78.0 million in the same period last year. -- Third quarter EBITDA increased 6.5% to $18.1 million compared to $17.0 million in the same period last year (see table at the...

2014-10-30 08:34:34

- Non-GAAP(1) operating earnings increased 6 percent to $566 million DUBLIN, Ohio, Oct. 30, 2014 /PRNewswire/ -- Cardinal Health today reported fiscal year 2015 first-quarter revenue of $24.1 billion and non-GAAP diluted earnings per share (EPS) from continuing operations of $1.00. Non-GAAP operating earnings increased 6 percent to $566 million. On a GAAP basis, operating earnings decreased 1 percent to $466 million, and diluted EPS from continuing operations decreased 21 percent to $0.78....

2014-10-30 08:34:25

- Record 675 HeartWare® Ventricular Assist Systems sold worldwide in Q3 FRAMINGHAM, Mass., Oct. 30, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $68.6 million for the third quarter ended September 30, 2014, a 25% increase compared to $54.8 million in revenue for the same period of 2013. During...

2014-10-30 08:34:11

SCHAUMBURG, IL, Oct. 30, 2014 /PRNewswire/ - Catamaran Corporation ("Catamaran" or the "Company") (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management ("PBM") services and technology, announces its financial results for the three and nine months ended September 30, 2014. Q3 2014 Highlights -- Revenue increased 53% to $5.5 billion in Q3 2014, compared to $3.6 billion in Q3 2013 -- Gross profit increased 22% to $351.5...

2014-10-30 08:33:59

$109.6 Million in 3Q 2014 Net Revenues Driven by Strong XIAFLEX Growth; Company Returns to Profitability with 3Q Non-GAAP EPS of $0.27 per Share CHESTERBROOK, Pa., Oct. 30, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the third quarter ending September 30, 2014. The Company highlighted important corporate, commercial, regulatory and clinical development updates from the...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related